A cancer-killing virus that scientists developed could one day improve the immune system’s ability to eradicate tumors in colon cancer patients, reports a new study. The preclinical research is a first step to showing that oncolytic virus CF33 can target hard-to-treat tumors that ‘handcuff’ the immune system and keep T cells from activating the immune system to kill cancer cells.
